Nielsen DL - Search Results

1

An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine.

Kümler I, Eefsen RL, Sørensen PG, Theile S, Fullerton A, Nielsen PG, Jensen BV, Nielsen DL. Kümler I, et al. Among authors: nielsen dl, nielsen pg. Cancer Chemother Pharmacol. 2019 Aug;84(2):441-446. doi: 10.1007/s00280-019-03819-0. Epub 2019 Apr 4. Cancer Chemother Pharmacol. 2019. PMID: 30949758

2

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.

Ryberg M, Nielsen D, Skovsgaard T, Hansen J, Jensen BV, Dombernowsky P. Ryberg M, et al. J Clin Oncol. 1998 Nov;16(11):3502-8. doi: 10.1200/JCO.1998.16.11.3502. J Clin Oncol. 1998. PMID: 9817267

3

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.

Nielsen D, Dombernowsky P, Larsen SK, Hansen OP, Skovsgaard T. Nielsen D, et al. Cancer Chemother Pharmacol. 2000;46(6):459-66. doi: 10.1007/s002800000178. Cancer Chemother Pharmacol. 2000. PMID: 11138459 Clinical Trial.

4

Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports.

Nielsen DL, Pfeiffer P, Jensen BV. Nielsen DL, et al. Acta Oncol. 2006;45(8):1137-8. doi: 10.1080/02841860600871764. Acta Oncol. 2006. PMID: 17118853 No abstract available.

5

Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil.

Pfeiffer P, Nielsen D, Bjerregaard J, Qvortrup C, Yilmaz M, Jensen B. Pfeiffer P, et al. Ann Oncol. 2008 Jun;19(6):1141-5. doi: 10.1093/annonc/mdn020. Epub 2008 Feb 14. Ann Oncol. 2008. PMID: 18281264 Free article.

6

Six cases of treatment with panitumumab in patients with severe hypersensitivity reactions to cetuximab.

Nielsen DL, Pfeiffer P, Jensen BV. Nielsen DL, et al. Ann Oncol. 2009 Apr;20(4):798. doi: 10.1093/annonc/mdp040. Epub 2009 Mar 2. Ann Oncol. 2009. PMID: 19254943 Free article. No abstract available.

7

Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer.

Appel JM, Jensen BV, Nielsen DL, Ryberg M, Zerahn B. Appel JM, et al. Among authors: nielsen dl. Int J Cardiovasc Imaging. 2010 Feb;26(2):217-23. doi: 10.1007/s10554-009-9518-2. Epub 2009 Oct 13. Int J Cardiovasc Imaging. 2010. PMID: 19823942

8

Liver resection and local ablation of breast cancer liver metastases--a systematic review.

Bergenfeldt M, Jensen BV, Skjoldbye B, Nielsen D. Bergenfeldt M, et al. Eur J Surg Oncol. 2011 Jul;37(7):549-57. doi: 10.1016/j.ejso.2011.04.013. Epub 2011 May 24. Eur J Surg Oncol. 2011. PMID: 21605957 Free article. Review.

9

Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer.

Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, Kruhøffer M, Luchinat C, Nielsen DL, Turano P. Bertini I, et al. Among authors: nielsen dl. Cancer Res. 2012 Jan 1;72(1):356-64. doi: 10.1158/0008-5472.CAN-11-1543. Epub 2011 Nov 11. Cancer Res. 2012. PMID: 22080567

10

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours.

Lassen U, Nielsen DL, Sørensen M, Winstedt L, Niskanen T, Stenberg Y, Pakola S, Stassen JM, Glazer S. Lassen U, et al. Among authors: nielsen dl. Br J Cancer. 2012 Feb 14;106(4):678-84. doi: 10.1038/bjc.2011.609. Epub 2012 Jan 24. Br J Cancer. 2012. PMID: 22333707 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page